© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
April 12, 2021
While this digital therapy failed to meet its primary endpoint in a recent clinical trial, results suggest it may improve paranoia in general.
April 08, 2021
This year, the March of the Living honors of Holocaust victims and survivors, the medical community, and Dr Anthony Fauci.
April 07, 2021
CRL cites lack of substantial evidence of efficacy needed for approval.
April 05, 2021
This once-daily sprinkleable capsule may help patients aged 6 to 17 years with attention-deficit/hyperactivity disorder.
April 01, 2021
Is this treatment for bipolar disorder risking patients’ heart health?
Government funding for the drug addiction crisis is on the way.
March 30, 2021
The first study to gather unsolicited patient responses via social media finds 3 negative themes.
Service animals can help save veterans’ lives.
March 25, 2021
This investigational dual orexin receptor antagonist improved sleep overnight and daytime functioning.
As patients flock to CBD as a “natural alternative” to medications, the FDA continues to crack down on false claims.